go-v.orgdoi

Considerations in the design of clinical trials for erectile dysfunction

Naif K. Alhathal, Talal Al‐Qaoud, Serge Carrier · Clinical Investigation · 2012

  • DOI 10.4155/cli.12.54
  • Publisher OMICS Publishing Group
  • Type article
  • Issued 2012

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Investigation · OMICS Publishing Group · article · 2012

Abstract

The naissance of the phosphodiesterase-5 inhibitors has dramatically fueled the research engine in pursuit of novel therapies for erectile dysfunction (ED). The epidemiological product of reports on penile implants, to multicenter, randomized, double-blinded, placebo-controlled trials on oral therapy and intracavernosal/intraurethral injection therapy, has translated into substantial assets for the treatment of patients with ED. However, at the heart of this issue, is that prior to the imbursement of effective and safe advents, investigators must consider several key points in the design stages of clinical trials.

The scope of the following review of the ED literature over the past two decades represents a methodological approach and a prospective quest for enriching current quality of evidence, focusing on considerations in the design stages of Phase III clinical trials of ED and highlighting the emphasis that needs to be placed in the process of subject enrollment, partner involvement and standardizatio...

Open the resolved locator · 10.4155/cli.12.54

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 10:28 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.4155/cli.12.54
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.